|
US20050096256A1
(en)
|
2003-07-01 |
2005-05-05 |
President And Fellows Of Harvard College |
Compositions for manipulating the lifespan and stress response of cells and organisms
|
|
US20090169585A1
(en)
*
|
2003-10-23 |
2009-07-02 |
Resveratrol Partners, Llc |
Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
|
|
US20050158376A1
(en)
*
|
2003-10-23 |
2005-07-21 |
Sardi William F. |
Dietary supplement and method of processing same
|
|
US8017634B2
(en)
|
2003-12-29 |
2011-09-13 |
President And Fellows Of Harvard College |
Compositions for treating obesity and insulin resistance disorders
|
|
EP1708689A2
(en)
*
|
2003-12-29 |
2006-10-11 |
The President and Fellows of Harvard College |
Compositions for treating or preventing obesity and insulin resistance disorders
|
|
AU2005207029B2
(en)
*
|
2004-01-20 |
2011-09-01 |
Brigham Young University |
Novel sirtuin activating compounds and methods for making the same
|
|
CN1964627B
(zh)
*
|
2004-06-04 |
2011-10-19 |
华盛顿大学 |
治疗神经病变的方法和组合物
|
|
UA91341C2
(ru)
|
2004-07-15 |
2010-07-26 |
Амр Текнолоджи, Інк. |
Арил- и гетероарилзамещенные тетрагидроизохинолины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
|
|
AU2006204699B2
(en)
*
|
2005-01-13 |
2012-04-26 |
Sirtris Pharmaceuticals, Inc. |
Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
|
|
WO2006104586A2
(en)
*
|
2005-02-15 |
2006-10-05 |
Joslin Diabetes Center |
Methods of diagnosis and treatment of metabolic disorders
|
|
US20090142335A1
(en)
*
|
2005-02-15 |
2009-06-04 |
Joslin Diabetes Center |
Methods of diagnosis and treatment of metabolic disorders
|
|
EP2805719A1
(en)
*
|
2005-03-30 |
2014-11-26 |
Glaxosmithkline LLC |
Nicotinamide riboside and analogues thereof
|
|
US20070014833A1
(en)
*
|
2005-03-30 |
2007-01-18 |
Sirtris Pharmaceuticals, Inc. |
Treatment of eye disorders with sirtuin modulators
|
|
AP2007004244A0
(en)
|
2005-05-10 |
2007-12-31 |
Intermune Inc |
Method of modulating stress-activated protein kinase system
|
|
US8546423B2
(en)
|
2005-05-18 |
2013-10-01 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
US20060292099A1
(en)
*
|
2005-05-25 |
2006-12-28 |
Michael Milburn |
Treatment of eye disorders with sirtuin modulators
|
|
WO2006138418A2
(en)
|
2005-06-14 |
2006-12-28 |
President And Fellows Of Harvard College |
Improvement of cognitive performance with sirtuin activators
|
|
US20070149466A1
(en)
*
|
2005-07-07 |
2007-06-28 |
Michael Milburn |
Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
|
|
CN101176786A
(zh)
*
|
2006-11-08 |
2008-05-14 |
中国科学院上海生命科学研究院 |
增加胰岛素敏感性的方法和组合物
|
|
WO2008060400A2
(en)
*
|
2006-11-15 |
2008-05-22 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin polymorphisms and methods of use thereof
|
|
SG178716A1
(en)
*
|
2007-01-16 |
2012-03-29 |
Ipintl Llc |
Novel composition for treating metabolic syndrome
|
|
WO2008119070A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Trustees Of Boston University |
Methods of treatment using sirt modulators and compositions containing sirt1 modulators
|
|
US8404275B2
(en)
*
|
2007-07-01 |
2013-03-26 |
Vitalis Llc |
Combination tablet with chewable outer layer
|
|
WO2009005803A1
(en)
*
|
2007-07-01 |
2009-01-08 |
Joseph Peter Habboushe |
Combination tablet with chewable outer layer
|
|
EP2018861A1
(en)
*
|
2007-07-26 |
2009-01-28 |
Laboratorios del Dr. Esteve S.A. |
5HT6-Ligands such as sulfonamide derivatives in drug-induced weight-gain
|
|
JP5337405B2
(ja)
|
2007-09-17 |
2013-11-06 |
ザ・ホスピタル・フォー・シック・チルドレン |
ゴーシェ病の治療方法
|
|
WO2009111031A2
(en)
*
|
2008-03-04 |
2009-09-11 |
Intra-Cellular Therapies, Inc. |
Methods of treating vasomotor symptoms
|
|
CN102088965B
(zh)
*
|
2008-05-13 |
2013-05-08 |
根梅迪卡治疗公司 |
水杨酸盐(酯)缀合物在制备用于治疗代谢性病症的药物中的应用
|
|
CA2666036C
(en)
*
|
2008-05-16 |
2017-09-12 |
Chien-Hung Chen |
Novel compositions and methods for treating hyperproliferative diseases
|
|
EP2296653B1
(en)
|
2008-06-03 |
2016-01-27 |
Intermune, Inc. |
Compounds and methods for treating inflammatory and fibrotic disorders
|
|
US9156812B2
(en)
|
2008-06-04 |
2015-10-13 |
Bristol-Myers Squibb Company |
Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
|
|
WO2010011836A2
(en)
*
|
2008-07-25 |
2010-01-28 |
Emory University |
Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof
|
|
CN102325532B
(zh)
|
2008-10-07 |
2015-06-17 |
Mpex医药有限公司 |
用于减轻肺部炎症的左氧氟沙星吸入剂
|
|
AU2009302478B2
(en)
*
|
2008-10-07 |
2015-09-03 |
Horizon Orphan Llc |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
|
WO2010107702A1
(en)
*
|
2009-03-16 |
2010-09-23 |
Ipintl, Llc |
Treating alzheimer's disease and osteoporosis and reducing aging
|
|
JP2012520342A
(ja)
*
|
2009-03-16 |
2012-09-06 |
ジェンメディカ・セラピューティックス・ソシエダッド・リミターダ |
代謝障害を処置するのに有用な抗炎症剤および抗酸化剤のコンジュゲート
|
|
CN102421424A
(zh)
*
|
2009-03-16 |
2012-04-18 |
根梅迪卡治疗公司 |
用于治疗代谢性疾病的组合疗法
|
|
CN102595902B
(zh)
*
|
2009-05-12 |
2015-04-29 |
阿尔巴尼分子研究公司 |
7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉及其用途
|
|
ES2446971T3
(es)
|
2009-05-12 |
2014-03-11 |
Albany Molecular Research, Inc. |
Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso
|
|
JP5739415B2
(ja)
|
2009-05-12 |
2015-06-24 |
ブリストル−マイヤーズ スクウィブ カンパニー |
(S)−7−([1,2,4]トリアゾロ[1,5−a]ピリジン−6−イル)−4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロイソキノリンの結晶形態およびその使用
|
|
WO2011002673A1
(en)
*
|
2009-07-01 |
2011-01-06 |
Temple University - Of The Commonwealth System Of Higher Education |
Leptin agonist and methods of use
|
|
DK2473504T3
(en)
|
2009-09-03 |
2015-03-16 |
Bioenergenix |
Heterocyclic Compounds for Inhibition of Passover
|
|
LT2473170T
(lt)
|
2009-09-04 |
2019-10-10 |
Horizon Orphan Llc |
Aerozolizuoto levofloksacino panaudojimas cistinės fibrozės gydymui
|
|
FI20106119A0
(fi)
*
|
2010-10-27 |
2010-10-27 |
Sirtuin Valley Oy |
Energia-aineenvaihduntaan vaikuttava koostumus
|
|
US8466197B2
(en)
|
2010-12-14 |
2013-06-18 |
Genmedica Therapeutics Sl |
Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
|
|
WO2012094462A2
(en)
|
2011-01-05 |
2012-07-12 |
Bioenergenix |
Heterocyclic compounds for the inhibition of pask
|
|
US8916561B2
(en)
|
2011-03-02 |
2014-12-23 |
Bioenergenix, Llc |
Substituted quinoxaline compounds for the inhibition of PASK
|
|
WO2012119046A2
(en)
|
2011-03-02 |
2012-09-07 |
Bioenergenix |
Heterocyclic compounds for the inhibition of pask
|
|
JP6140682B2
(ja)
*
|
2011-04-15 |
2017-05-31 |
ネステク ソシエテ アノニム |
サーチュイン遺伝子発現の調節方法
|
|
JP2012236793A
(ja)
*
|
2011-05-11 |
2012-12-06 |
Kikkoman Corp |
Ampk活性化剤
|
|
MX2014000419A
(es)
|
2011-07-15 |
2014-09-22 |
Nusirt Sciences Inc |
Composicones y metodos para modular trayectorias metabolicas.
|
|
WO2013063078A1
(en)
|
2011-10-28 |
2013-05-02 |
Vitalis Llc |
Anti-flush compositions
|
|
WO2013074948A1
(en)
|
2011-11-16 |
2013-05-23 |
Resveratrol Partners, Llc |
Compositions containing resveratrol and nucleotides
|
|
US9745279B2
(en)
|
2011-12-27 |
2017-08-29 |
Tokiwa Phytochemical Co., Ltd. |
Sirtuin activator
|
|
JO3407B1
(ar)
|
2012-05-31 |
2019-10-20 |
Eisai R&D Man Co Ltd |
مركبات رباعي هيدرو بيرازولو بيريميدين
|
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
|
TWI485145B
(zh)
|
2012-10-26 |
2015-05-21 |
財團法人工業技術研究院 |
P型有機半導體材料與光電元件
|
|
BR112015010947A2
(en)
|
2012-11-13 |
2018-06-05 |
Nusirt Sciences, Inc. |
compositions and methods for increasing energy metabolism.
|
|
SG11201507046UA
(en)
*
|
2013-03-15 |
2015-10-29 |
Nusirt Sciences Inc |
Leucine and nicotinic acid reduces lipid levels
|
|
EP2801357A1
(en)
|
2013-05-10 |
2014-11-12 |
IMD Natural Solutions GmbH |
Carboxylated stilbenes for activating AMPK and sirtuins
|
|
RU2692485C2
(ru)
|
2014-04-02 |
2019-06-25 |
Интермьюн, Инк. |
Противофиброзные пиридиноны
|
|
AU2016219879A1
(en)
*
|
2015-02-19 |
2017-08-24 |
Purdue Pharma L.P. |
Methods and compositions for decreasing gastric emptying
|
|
CN105153090A
(zh)
*
|
2015-07-17 |
2015-12-16 |
浙江海洋学院 |
4′-溴-7-异戊烯氧基-2,3-二氢黄酮和制备方法以及在制备抗抑郁药物中的应用
|
|
CN105380955A
(zh)
*
|
2015-09-24 |
2016-03-09 |
成都普瑞法科技开发有限公司 |
土大黄苷在治疗溃疡性结肠炎药物中的应用
|
|
US20180169085A1
(en)
*
|
2016-12-19 |
2018-06-21 |
Augusta University Reserch Institute, Inc. |
Combination Therapy for Hemorrhagic Injury
|
|
WO2019108877A1
(en)
*
|
2017-12-01 |
2019-06-06 |
University Of Hawaii |
GSK-3β INHIBITORS AND USE THEREOF IN METHODS OF TREATMENT
|
|
US20210393621A1
(en)
|
2018-10-26 |
2021-12-23 |
The Research Foundation For The State University Of New York |
Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
|
|
IT201900003325A1
(it)
*
|
2019-03-07 |
2020-09-07 |
C I A M S R L |
Composizione per la prevenzione e trattamento della dermatite atopica
|
|
WO2021096882A1
(en)
*
|
2019-11-11 |
2021-05-20 |
Nusirt Sciences, Inc. |
Compositions, methods and kits for altering adipocytes
|
|
KR20240101561A
(ko)
|
2021-10-14 |
2024-07-02 |
인사이트 코포레이션 |
Kras의 저해제로서의 퀴놀린 화합물
|
|
WO2025049514A1
(en)
*
|
2023-08-30 |
2025-03-06 |
Sirona Biosciences Inc. |
Compositions and methods with flavonoids
|